The nurse is planning discharge education for a client with a new prescription for montelukast. Which adverse effect should the nurse instruct the client to report to the healthcare provider?

A. Increases cardiac output: Dobutamine is a beta-1 adrenergic agonist that primarily increases the strength of myocardial contractions, leading to enhanced cardiac output. It is commonly used in clients with heart failure or cardiogenic shock to improve tissue perfusion without significantly increasing heart rate.

B. Promotes diuresis: Dobutamine does not have a direct diuretic effect. While improved cardiac output may indirectly enhance renal perfusion and urine output, promoting diuresis is not its primary therapeutic action.

C. Increases blood pressure: Dobutamine may slightly increase systolic blood pressure due to improved cardiac output, but it is not primarily used as an antihypotensive agent. Its main role is enhancing myocardial contractility rather than raising blood pressure.

D. Inhibits platelet aggregation: Dobutamine has no effect on platelet function or aggregation. Its mechanism of action is limited to stimulating beta-1 receptors in the heart to improve contractility.

A. "This medication is safe to take with my diagnosis of hypertension.": Ipratropium is an anticholinergic bronchodilator that does not significantly affect blood pressure. Clients with hypertension can safely use it to manage bronchospasm without increasing cardiovascular risk, reflecting correct understanding of the medication.

B. "I will take this medication during an acute asthma attack.": Ipratropium is not a first-line agent for acute asthma attacks. Short-acting beta-agonists like albuterol are preferred for rapid relief, as ipratropium has a slower onset and is more effective as maintenance therapy.

C. "If dry mouth occurs, I should stop taking this medication.": Dry mouth is a common, mild side effect of ipratropium and does not require discontinuation. Supportive measures like sipping fluids or using sugarless candy are appropriate rather than stopping therapy abruptly.

D. "A common side effect of this medication is urinary frequency.": Urinary retention, not frequency, is a potential side effect of anticholinergic medications. Increased urination is not typical, so this statement reflects a misunderstanding.